BioCentury
ARTICLE | Top Story

TetraLogic raises $32 million

August 10, 2010 10:44 PM UTC

TetraLogic Pharmaceuticals (Malvern, Pa.) raised $32 million in a series C round led by new investor Clarus. Hatteras Venture Partners, also a new investor, and existing investors Amgen Ventures; HealthCare Ventures; Latterell Venture Partners; Novitas Capital; Quaker BioVentures; and Vertical Group also participated. ...